These days, two reagents of WIZ been approved!
WIZ's two reagents, HBA1C assay kits (fluorescent immunochromatography) and the SARS-CoV-2 Antigen Rapid Test (Colloidal gold) (Anterior nasal) have been approved by the Medical Device Authority (MDA) of Malaysia and began market access. It has laid another foundation stone for unblocking the international operation channels, giving full play to its own product marketing advantages, strengthening the high-end operation and diversified cooperation, speeding up the "going out", and realizing the sustainable development of the overseas market.
little rise shows better reaction #
Glycosylated hemoglobin assay Kit (Fluorescence immunochromatography)
At present, there are more than 80 million people need to be screened for diabetes in China, the huge demand and severe facts show that it is urgent to promote the long-term stability of blood glucose screening! Traditional diabetes diagnosis and treatment monitoring using fasting blood glucose, postprandial blood glucose and oral glucose tolerance test, etc., it is hard to reflect the long-term blood glucose level, and HbA1c, as the golden standard to reflect the long-term blood glucose level, also an important indicator to monitor the treatment of diabetes.
HbA1c (glycated hemoglobin) is a glycoprotein formed by a slow, irreversible, non-enzymatic reaction between valine residues at the end of the hemoglobin beta chain and hexose (mainly glucose) in the blood, which reflects the average plasma glucose level during the entire life cycle of red blood cells during 8~12 weeks.
WIZ's glycated hemoglobin assay kit (fluorescence immunochromatography) requires only 10μL of whole blood sample to produce results in 15 minutes. The product also has the advantages of wide linear range, high precision, simple operation, etc., for the early screening and diagnosis of diabetes mellitus and the evaluation of the effect of blood glucose control programs and the differentiation of stress hyperglycemia and diabetes.
Keep guarding, keep watching #
SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)
On the issue of human survival, WIZ has made every effort to promote the research and development and production of SARS-CoV-2 testing reagents, helping the countries like Malaysia, the Netherlands, Finland, Brazil and so on to win the battle against the epidemic.
WIZ's SARS-CoV-2 Antigen nasal Test kit (Colloidal Gold), which can read results in 15 to 20 minutes, is a convenient and fast test that can be used to screen and diagnose SARS-CoV-2 infection without the need for professional technicians or laboratory equipment, and can be performed in clinical, medical or other settings to meet the overall needs of Malaysia's current epidemic prevention and control.
As a high-tech company engaging in the research and development, production and sales of rapid diagnostic reagents and instruments, WIZ has always been committed to the purpose of "focusing on diagnostic technology and improving the quality of life", concentrating on technological innovation, developing POCT detection reagents and instruments, with a view to getting success in the field of POCT rapid diagnostic reagents. At present, WIZ has more than 120 certified reagent menus at home and abroad, covering SARS-CoV-2 solution, gastrointestinal function/infection test, infectious disease, thyroid function test, AIDS and other series products. WIZ already possesses a platform for the developing and preparing the antigen and antibody raw materials, a mature immunochromatography technology platform, and a chemiluminescence platform, and focuses on the layout of microfluidic, molecular diagnosis and other platforms.
In the future, we hope to provide more customers with high-quality products and services through more project output.
